Clinical Trial Update: A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating recombinant human thrombopoietin for managing immune thrombocytopenia in pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Pregnancy

Drugs mentioned

• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia, Pregnancy | Phase 3 | Status: COMPLETED